Abstract: A method, system and computer readable medium for running a legacy application on a non-legacy device. Operating parameters of the non-legacy device when running the legacy application are set based on one or more pre-determined heuristics for adjustment of operating parameters of the newer system when running the legacy application on the non-legacy device from one or more performance metrics and other performance information.

Abstract: A method including rendering graphics for an application using graphics processing units (GPUs). The method including dividing responsibility for processing pieces of geometry of an image frame during an analysis pre-pass phase of rendering between the plurality of GPUs, wherein each of the pieces of geometry is assigned to a corresponding GPU. The method including determining in the analysis pre-pass phase overlap of each of the pieces of geometry with each screen regions. The method including generating information at the GPUs regarding the pieces of geometry and their relations to the screen regions based on the overlap of each of the pieces of geometry with each of the screen regions. The method including assigning the screen regions to the GPUs based on the information for purposes of rendering the pieces of geometry during a subsequent phase of rendering.

Abstract: The present disclosure provides methods of treating myeloid malignancies in a subject with a Bcl-2 inhibitor, in particularly 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-N-((4-((((1r,4r)-4-hydroxy-4-methylcyclohexyl)methyl)amino)-3-nitrophenyl)sulfonyl)-4-(2-((S)-2-(2-isopropylphenyl)pyrrolidin-1-yl)-7-azaspiro[3.5]nonan-7-yl)benzamide or a pharmaceutically acceptable salt thereof, in combination with azacitidine.

Abstract: A method for graphics processing. The method including rendering graphics for an application using a plurality of graphics processing units (GPUs). The method including using the plurality of GPUs in collaboration to render an image frame including a plurality of pieces of geometry. The method including during a pre-pass phase of rendering, generating information at the GPUs regarding the plurality of pieces of geometry and their relation to a plurality of screen regions. The method including assigning the plurality of screen regions to the plurality of GPUs based on the information for purposes of rendering the plurality of pieces of geometry in a subsequent phase of rendering.

Abstract: The present invention is directed to isolated nucleic acid molecules and polypeptides of thraustochytrid polyunsaturated fatty acid (PUFA) synthases involved in the production of PUFAs, including PUFAs enriched in docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), or a combination thereof. The present invention is directed to vectors and host cells comprising the nucleic acid molecules, polypeptides encoded by the nucleic acid molecules, compositions comprising the nucleic acid molecules or polypeptides, and methods of making and uses thereof.

Abstract: An inductive power system including an inductive power transmitter coupled to a non-conductive medium, and a power cord that electrically couples the transmitter to an AC power source. The inductive power transmitter is configured to emit an electromagnetic field based on the received AC power. There is an inductive power receiver coupled to the non-conductive medium and separated from the transmitter, wherein the receiver is configured to receive the electromagnetic field after it has passed through the non-conductive medium and in response develop power. A power cord electrically couples the developed power to a power sink.

Abstract: The invention generally relates to dextran fibers which are preferably electrospun and devices formed from such fibers. In particular, such devices may include substances of interest (such as therapeutic substances) associated with the electrospun fibers. Upon exposure to a liquid the electrospun fibers dissolve immediately and the substances of interest are released into the liquid. Exemplary devices include bandages formed from electrospun dextran fibers and associated agents that promote hemostasis, such as thrombin and fibrinogen.

Abstract: A method including rendering graphics for an application using graphics processing units (GPUs). The method including dividing responsibility for processing pieces of geometry of an image frame during an analysis pre-pass phase of rendering between the plurality of GPUs, wherein each of the pieces of geometry is assigned to a corresponding GPU. The method including determining in the analysis pre-pass phase overlap of each of the pieces of geometry with each screen regions. The method including generating information at the GPUs regarding the pieces of geometry and their relations to the screen regions based on the overlap of each of the pieces of geometry with each of the screen regions. The method including assigning the screen regions to the GPUs based on the information for purposes of rendering the pieces of geometry during a subsequent phase of rendering.

Abstract: A method and apparatus for selectively connecting a first fluid communication region to a further fluid communication region are disclosed. The apparatus comprises an elongate housing, locatable in a wellbore, comprising a first end portion associated with a first fluid communication region; a sheath member axially slidable within the housing and biased towards the first end portion via at least one biasing element; and an elongate shuttle member axially slidable within the housing and slidably locatable in a sealed relationship or non-sealed relationship with the sheath member; wherein the biasing element provides a predetermined biasing force that determines a threshold pressure which must be exceeded by a fluid pressure in the first fluid communication region to permit axial movement of the sheath member away from the first fluid communication region or towards a further fluid communication region.

Abstract: A method for graphics processing. The method including rendering graphics for an application using a plurality of graphics processing units (GPUs). The method including using the plurality of GPUs in collaboration to render an image frame including a plurality of pieces of geometry. The method including during a pre-pass phase of rendering, generating information at the GPUs regarding the plurality of pieces of geometry and their relation to a plurality of screen regions. The method including assigning the plurality of screen regions to the plurality of GPUs based on the information for purposes of rendering the plurality of pieces of geometry in a subsequent phase of rendering.

Abstract: The present invention relates to a group of resorcinol derivatives as a pharmaceutically active compounds and methods of preparation thereof. Resorcinol derivatives have been used to treat various diseases and disorders. While such treatments hold promise, there remains a need in the art for more effective treatments and this has been brought about by way of the resorcinol derivative of the invention.

Abstract: A mobile workstation with adjustable height of the present disclosure may comprise a top assembly, an adjustment assembly, and a bottom assembly. Adjustment assembly may comprise telescopically engaged segments. One or more pulleys or pulley assemblies may be disposed within one or more of the segments to allow for withdrawing and retracting segments from one another at the same rate. Actuation of the raising or lowering of the overall height of the mobile workstation may be realized through either a manual actuation or an electronic element such as a linear actuator.

Abstract: One or more aspects of the present disclosure are directed to network optimization solutions provided as software agents (applications) executed on network nodes in a heterogenous multi-vendor environment to provide cross-layer network optimization and ensure availability of network resources to meet associated Quality of Experience (QoE) and Quality of Service (QoS). In one aspect, a network slicing engine is configured to receive at least one request from at least one network endpoint for access to the heterogeneous multi-vendor network for data transmission; receive information on state of operation of a plurality of communication links between the plurality of nodes; determine a set of data transmission routes for the request; assign a network slice for serving the request; determine, from the set of data transmission routes, an end-to-end route for the network slice; and send network traffic associated with the request using the network slice and over the end-to-end route.

Abstract: A device and computer program product including one or more processors and a memory coupled to the one or more processors. The device being configured to selectively run in a timing testing mode or in a mode of operation other than the timing testing mode, wherein in the timing testing mode the device is configured to attempt to induce skew.

Abstract: Additive manufacturing apparatus, along with methods of forming an object therewith, are provided. The additive manufacturing apparatus may include at least one build unit; a build platform (such as a rotating build platform); and a pair of collectors positioned on the apparatus such that a first collector contacts an outer surface of an object as it is formed on the build platform and a second collector contacts an inner surface of the object as it is formed on the build platform.

Abstract: The present disclosure provides methods of treating B-cell malignancy in a subject with a Bcl-2 inhibitor, in particularly 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-N-((4-((((1r,4r)-4-hydroxy-4-methylcyclohexyl)methyl)amino)-3-nitrophenyl)sulfonyl)-4-(2-((S)-2-(2-isopropylphenyl)pyrrolidin-1-yl)-7-azaspiro[3.5]nonan-7-yl)benzamide or a pharmaceutically acceptable salt thereof, or its combination with a Bruton's tyrosine kinase (BTK) inhibitor, particularly (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo-[1,5-a]pyrimidine-3-carboxamide or a pharmaceutically acceptable salt thereof.

Abstract: At least some aspects of this disclosure include one or more auxinic herbicides with relatively low volatility. Some of these compounds may be especially useful when used in the process of growing commercially important plants. Methods for using these actives to control the growth and spread of unwanted plants and/or to hasten the growth of desirable plants are also disclosed herein.

Abstract: An anode apparatus for mounting on an external surface of a concrete structure to provide cathodic protection of metal members in the concrete uses a pre-assembled body which is typically elongate carrying a longitudinal anode, which can be sacrificial or impressed current, together with a supporting material having a front face for attachment to the surface and an impermeable plastic covering material at the rear face covering the anode and the supporting material when the front face is attached to the surface of the concrete. A channel defined on the front face is arranged to receive a layer of a conformable ionically conductive adhesive material for attachment to the external surface. A distance of the edge of the covering material is arranged to be similar to a distance of the metal from the external surface such that wetting and drying effects of environmental moisture are the same for the anode as for the metal components.

Abstract: A device having a Graphics Processing Unit (GPU) may be configured to selectively run in a normal mode or a timing testing mode. In the timing testing mode the device is configured to disrupt timing of processing that takes place on the GPU while running an application with the GPU and test the application for errors in device hardware component and/or software component synchronization while the device is running in the timing testing mode.

Abstract: The present invention relates to a group of novel compounds, methods for their manufacture and the use of these compounds as research tools and as pharmaceuticals. The novel compounds are analogues of cannabidiol (CBD). CBD is a non-psychoactive cannabinoid which has been used to treat various diseases and disorders. While such treatments hold promise, there remains a need in the art for more effective treatments and this has been brought about by way of novel cannabidiol compounds.